Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.
Nikolaienko O, Eikesdal HP, Ognedal E, Gilje B, Lundgren S, Blix ES, Espelid H, Geisler J, Geisler S, Janssen EAM, Yndestad S, Minsaas L, Leirvaag B, Lillestøl R, Knappskog S, Lønning PE.
Nikolaienko O, et al. Among authors: lundgren s.
Genome Med. 2023 Dec 6;15(1):104. doi: 10.1186/s13073-023-01262-8.
Genome Med. 2023.
PMID: 38053165
Free PMC article.